Twinaqt Tablet HIV

Product Description

Twinaqt 50/300 Tablet contains Dolutegravir and Lamivudine. Both Dolutegravir and Lamivudine are nucleoside reverse transcriptase inhibitors. Twinaqt 50/300 Tablet works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes necessary for virus reproduction. Together, Twinaqt 50/300 Tablet helps treat HIV infections.

Twinaqt 50/300 Tablet is a prescription medication. You should take this medicine exactly as prescribed by the doctor. The common side effects of Twinaqt 50/300 Tablet are nausea, headache, tiredness, diarrhoea, dizziness, anxiety, gas, difficulty falling asleep or staying asleep and muscle weakness. Most of these side effects of Twinaqt 50/300 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Twinaqt 50/300 Tablet is not recommended to take Twinaqt 50/300 Tablet if you are allergic to any of its contents. Twinaqt 50/300 Tablet is not recommended for use in children and adolescents under 18 years of age. Twinaqt 50/300 Tablet may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy. Consumption of alcohol may increase the risk of side effects; therefore, avoid alcohol consumption. You should not become pregnant while you are taking Twinaqt 50/300 Tablet . Talk to your doctor about effective birth control methods that you can use during your treatment. If you become pregnant while taking Twinaqt 50/300 Tablet , call your doctor immediately. You should not breastfeed if you are infected with HIV or if you are taking Twinaqt 50/300 Tablet .